Capital Performance Advisors LLP Mirum Pharmaceuticals, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 16 shares of MIRM stock, worth $746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$746% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$307 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$209 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$161 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$151 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$143 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.71B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...